Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo
Ze Tao
1
,
Yuehua Liu
1
,
Hao Yang
1
,
Yanru Feng
1
,
Heng Li
1
,
Qiuxiao Shi
1
,
Shengfu Li
1
,
JINGQIU CHENG
1, 2
,
Xiaofeng Lu
1, 2
Publication type: Journal Article
Publication date: 2020-08-17
scimago Q1
wos Q1
SJR: 1.142
CiteScore: 9.2
Impact factor: 5.4
ISSN: 15257797, 15264602
PubMed ID:
32804484
Materials Chemistry
Polymers and Plastics
Bioengineering
Biomaterials
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an attractive antitumor drug candidate for precision cancer therapy due to its superior selective cytotoxicity in a variety of tum...
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
International Journal of Pharmaceutics
2 publications, 20%
|
|
|
Future Oncology
1 publication, 10%
|
|
|
Nano Research
1 publication, 10%
|
|
|
Molecular Pharmaceutics
1 publication, 10%
|
|
|
Journal of Immunology Research
1 publication, 10%
|
|
|
mAbs
1 publication, 10%
|
|
|
Journal of Drug Delivery Science and Technology
1 publication, 10%
|
|
|
Cancer Medicine
1 publication, 10%
|
|
|
Russian Chemical Reviews
1 publication, 10%
|
|
|
1
2
|
Publishers
|
1
2
3
|
|
|
Elsevier
3 publications, 30%
|
|
|
Taylor & Francis
2 publications, 20%
|
|
|
Springer Nature
1 publication, 10%
|
|
|
American Chemical Society (ACS)
1 publication, 10%
|
|
|
Hindawi Limited
1 publication, 10%
|
|
|
Wiley
1 publication, 10%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 10%
|
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
10
Total citations:
10
Citations from 2024:
4
(40%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Tao Z. et al. Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo // Biomacromolecules. 2020. Vol. 21. No. 10. pp. 4017-4029.
GOST all authors (up to 50)
Copy
Tao Z., Liu Y., Yang H., Feng Y., Li H., Shi Q., Li S., CHENG J., Lu X. Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo // Biomacromolecules. 2020. Vol. 21. No. 10. pp. 4017-4029.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/acs.biomac.0c00785
UR - https://doi.org/10.1021/acs.biomac.0c00785
TI - Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo
T2 - Biomacromolecules
AU - Tao, Ze
AU - Liu, Yuehua
AU - Yang, Hao
AU - Feng, Yanru
AU - Li, Heng
AU - Shi, Qiuxiao
AU - Li, Shengfu
AU - CHENG, JINGQIU
AU - Lu, Xiaofeng
PY - 2020
DA - 2020/08/17
PB - American Chemical Society (ACS)
SP - 4017-4029
IS - 10
VL - 21
PMID - 32804484
SN - 1525-7797
SN - 1526-4602
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Tao,
author = {Ze Tao and Yuehua Liu and Hao Yang and Yanru Feng and Heng Li and Qiuxiao Shi and Shengfu Li and JINGQIU CHENG and Xiaofeng Lu},
title = {Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo},
journal = {Biomacromolecules},
year = {2020},
volume = {21},
publisher = {American Chemical Society (ACS)},
month = {aug},
url = {https://doi.org/10.1021/acs.biomac.0c00785},
number = {10},
pages = {4017--4029},
doi = {10.1021/acs.biomac.0c00785}
}
Cite this
MLA
Copy
Tao, Ze, et al. “Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo.” Biomacromolecules, vol. 21, no. 10, Aug. 2020, pp. 4017-4029. https://doi.org/10.1021/acs.biomac.0c00785.